Razia Moorad, Edwards Kasonkanji, Joe Gumulira, Yolanda Gondwe, Morgan Dewey, Yue Pan, Alice Peng, Linda J Pluta, Evaristar Kudowa, Richard Nyasosela, Tamiwe Tomoka, Hannock Tweya, Tom Heller, Salem Gugsa, Sam Phiri, Dominic T Moore, Blossom Damania, Matthew Painschab, Mina C Hosseinipour, Dirk P Dittmer
Kaposi sarcoma (KS) is the most common cancer in people living with HIV (PLWH) in many countries where KS-associated herpesvirus is endemic. Treatment has changed little in 20 years, but the disease presentation has. This prospective cohort study enrolled 122 human immunodeficiency virus (HIV) positive KS patients between 2017 and 2019 in Malawi. Participants were treated with bleomycin, vincristine and combination antiretroviral therapy, the local standard of care. One-year overall survival was 61%, and progression-free survival was 58%...
August 21, 2023: International Journal of Cancer. Journal International du Cancer